(Haifa, Israel) Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products is evaluating strategic opportunities to co-develop and commercialize cell therapy products in Japan.
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market (CNN)
